VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years

CompletedOBSERVATIONAL
Enrollment

3,910

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 15, 2018

Study Completion Date

February 15, 2018

Conditions
AML
Interventions
OTHER

Registry of AML patients > 60 years

Trial Locations (20)

Unknown

Hospital General Universitario de Alicante, Alicante

ICO-Hospital Germans Trias i Pujol, Badalona

Hospital General Universitari de Castelló, Castelló

Hospital San Pedro Alcántara, Cáceres

Hospital Universitario Reina Sofía, Córdoba

Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas

Hospital Lucus Augusti, Lugo

CIBERONC, Instituto Carlos III, Madrid

Hospital Clínico San Carlos, Madrid

Hospital General Universitario Gregorio Marañón, Madrid

Hospital Univeristario Ramón y Cajal, Madrid

Hospital Universitario 12 de Octubre, Complutense University, i+12, CNIO, Madrid

Hospital Universitario Fundación Jiménez Díaz, Madrid

Hospital General Universitario Morales Meseguer, Murcia

Hospital Universitario Central de Asturias, Oviedo

Hospital Universitario Marqués de Valdecilla, Santander

Hospital Universitario Virgen del Rocío, Instituto de Biomedicina, Seville

Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia

Hospital General Universitario de Valencia, Valencia

Hospital Universitari i Politècnic La Fe, Valencia

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT02606825 - VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years | Biotech Hunter | Biotech Hunter